Korro Bio
KRRO
40 hedge funds and large institutions have $302M invested in Korro Bio in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 2 reducing their positions, and 18 closing their positions.
2,296% more capital invested
Capital invested by funds: $12.6M → $302M (+$289M)
650% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 2
81.37% more ownership
Funds ownership: 0.58% → 81.95% (+81%)
6% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 18
2% less funds holding
Funds holding: 41 → 40 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AVLSA
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
+$36.9M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$35.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$24M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$17.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$444K |
| 2 |
Goldman Sachs
New York
|
-$78.5K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$50K |
| 4 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$46.1K |
| 5 |
WPW
Waldron Private Wealth
Bridgeville,
Pennsylvania
|
-$26.1K |
KRRO Hedge Fund Activity: Q4 2023 in Review
40 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2023, worth a combined $302M — up 2,296% from $12.6M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of KRRO and 17 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 15 added.
The largest buyer was Atlas Venture Life Science Advisors, opening a new position worth an estimated $36.9M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $444K sold.
- 40 institutional investors held Korro Bio (KRRO) as of Q4 2023, down from 41 in Q3 2023.
- Funds reported $302M of Korro Bio stock for Q4 2023, up 2,296% quarter-over-quarter.
- 17 funds opened new Korro Bio positions in Q4 2023 and 18 closed out, a net change of -1 holder.
- The largest Korro Bio buyer in Q4 2023 was Atlas Venture Life Science Advisors, an estimated $36.9M added.
- The largest Korro Bio seller in Q4 2023 was Adage Capital Partners, an estimated $444K sold.
Based on aggregated 13F filings for Q4 2023.